Neurogene Inc.
USD32.19
-0.09 (-0.29%)
CEO
Rachel L. McMinn
IPO Date
2014-03-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$32.04
Prev. Close
$32.28
Day Low
$30.34
Day High
$32.95
52W Low
$14.65
52W High
$37.27
Market Cap
$0.51B
Volume
0.07M
| -5.3 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -19.5% | -16.3% | 0.09 | 8.72 | -6.8 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -56.0% | -50.5% | 0.05 | 12.74 | -2.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 55.0% | -49.8% | -0.07 | 6.81 | -105.0 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -17.4% | -15.8% | 0.06 | 24.66 | -439.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -49.0% | -47.2% | 0.01 | 30.28 | -95.9 |
| 31 Dec 2018 | FY | 100.0% | -126.3% | -43.5% | -40.7% | 0.00 | 16.68 | -32.2 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -50.7% | -45.5% | 0.00 | 9.93 | -109.9 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -25.6% | -24.0% | 0.00 | 10.87 | -168.6 |
| -3.2 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -7.9% | -7.3% | 0.04 | 18.39 | -4.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -8.1% | -7.4% | 0.05 | 18.07 | -3.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -7.8% | -7.2% | 0.05 | 21.03 | -2.7 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -6.3% | -5.8% | 0.04 | 20.84 | -4.4 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -14.7% | -12.3% | 0.11 | 9.09 | -8.8 |
| 30 Jun 2024 | Q2 | 11.7% | -1999.1% | -11.9% | -10.3% | 0.09 | 12.17 | -9.3 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -9.9% | -8.7% | 0.08 | 14.74 | -11.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 1.3% | 1.1% | 0.09 | 8.72 | 26.1 |